Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹19.7 LAdmitted-Finance | L1 | Admitted-Finance | |
| 2 | L2₹21.2 L+₹1.5 L (7.62%)Admitted-Finance | L2 | Admitted-Finance | |
| 3 | L3₹26.5 L+₹6.7 L (34.2%)Admitted-Finance | L3 | Admitted-Finance | |
| 4 | L4₹33.5 L+₹13.8 L (70.0%)Admitted-Finance PLOT NO 391 INDUSTRIAL AREA PHASE 1 PANCHKULA PANCHKULA HARYANA 134113 | PANCHKULA | HARYANA | 134113 | L4 | Admitted-Finance | |
| 5 | Rejected-Technical | - | Rejected-Technical Minutes Enclosed |
| Sl No | Description | Qty | Unit | Multani Pharmaceuticals Ltd. L2 | Humongous Labs (OPC) Pvt. Ltd. L1 | SHREE KRISHNA ANALYTICAL SERVICES PVT LTD L3 | IDMA LABORATORIES LIMITED L4 |
|---|---|---|---|---|---|---|---|
| 1.00EMPANELMENT OF ANALYTICAL TESTING LABORATORIES | |||||||
| 1.01 | Intra Lipid Injection 10%. | 1 | each | - | - | - | - |
| 2.01 | IrinotecanInj. IP/USP100mg/5ml | 1 | each | - | 2,850 ₹3,363 Lowest | - | - |
| 3.01 | Inj. Zuclopenthixol Long action 200mg/ml | 1 | each | - | - | - | - |
| 4.01 | Inj. Mivacurium Chloride 2mg/ml | 1 | each | - | - | - | - |
| 5.01 | Inj. Mitomycin-C 2mg, single dose vial | 1 | each | - | - | - | - |
| 6.01 | Buprenorphine Transdermal Patch 5mcg, Patches | 1 | each | - | - | 2,500 ₹2,950 Lowest | - |
| 7.01 | Buprenorphine Transdermal Patch 10mcg, Patches | 1 | each | - | - | 2,500 ₹2,950 Lowest | - |
| 8.01 | Buprenorphine Transdermal Patch 20mcg, Patches | 1 | each | - | - | 2,500 ₹2,950 Lowest | - |
| 9.01 | Inj. Liposomal Doxirobucin 20mg/10ml, Vial | 1 | each | - | - | 3,000 ₹3,540 Lowest | - |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
17 Jun 2026, 4:00 pmClosed
Managing Director -JKMSCL
JKMSCL Corporate office Jammu/Srinagar
EMPANELMENT OF ANALYTICAL TESTING LABORATORIES
2026_HME_310814_1
JKMSCL/ANALYTICAL LABS/2026/694 DATED 20-05-2026
Open Tender
Medicines
Item Wise
720 days
Jammu / Srinagar
Please refer Tender documents.
2 documents required · 2 mandatory
₹11,800
Yes
As Per NIT
₹1 L
Yes
JKMSCL Corporate office Jammu/Srinagar
12 Oct 2026
23 May 2026
19 Jun 2026
23 May 2026
17 Jun 2026
2 Jun 2026
23 May 2026 - 30 May 2026
30 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1EMPANELMENT OF ANALYTICAL TESTING LABORATORIES | |||||
| 1.01 | Intra Lipid Injection 10%. | - | each | 55 | - |
| 2.01 | IrinotecanInj. IP/USP100mg/5ml | - | each | 65 | - |
| 3.01 | Inj. Zuclopenthixol Long action 200mg/ml | - | each | 75 | - |
| 4.01 | Inj. Mivacurium Chloride 2mg/ml | - | each | 55 | - |
| 5.01 | Inj. Mitomycin-C 2mg, single dose vial | - | each | 65 | - |
| 6.01 | Buprenorphine Transdermal Patch 5mcg, Patches | - | each | 75 | - |
| 7.01 | Buprenorphine Transdermal Patch 10mcg, Patches | - | each | 55 | - |
| 8.01 | Buprenorphine Transdermal Patch 20mcg, Patches | - | each | 65 | - |
| 9.01 | Inj. Liposomal Doxirobucin 20mg/10ml, Vial | - | each | 75 | - |
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.68 MB
BOQ_1005306.xls
BOQ • 2.15 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .